Clinical Trial Update: Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating combined oral contraceptives for treatment of Premenstrual Dysphoric Disorder in individuals with Bipolar Disorder has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Premenstrual Dysphoric Disorder

Drugs mentioned

• Oral contraceptives (combined estrogen-progestin) (Combined estrogen-progestin oral contraceptive)

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Premenstrual Dysphoric Disorder, Bipolar Disorder | Phase 2 | Status: COMPLETED